CNMD CONMED CORP revenue, earnings and financials

For the quarter ended June 30, 2026, CONMED CORP reported revenue of $343M (up 0.3% from a year earlier), net income of $23.1M and diluted EPS of $0.77; for the fiscal year ended December 2025 revenue was $1.37B, up 5.2% on the year before.

CNMD annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $1.37B, gross profit $750M, operating income $103M, net income $47.1M (margin 3.4%), EPS $1.51
• Fiscal year ended Dec 2024: revenue $1.31B, gross profit $733M, operating income $200M, net income $132M (margin 10.1%), EPS $4.25
• Fiscal year ended Dec 2023: revenue $1.24B, gross profit $676M, operating income $121M, net income $64.5M (margin 5.2%), EPS $2.04
• Fiscal year ended Dec 2022: revenue $1.05B, gross profit $571M, operating income $70.1M, net income −$80.6M (margin -7.7%), EPS −$2.68
• Fiscal year ended Dec 2021: revenue $1.01B, gross profit $568M, operating income $110M, net income $62.5M (margin 6.2%), EPS $1.94

CNMD quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $343M (up 0.3% year over year), net income $23.1M, EPS $0.77
• Quarter ended Sep 30, 2025: revenue $338M (up 6.7% year over year), net income $2.86M, EPS $0.09
• Quarter ended Jun 30, 2025: revenue $342M (up 3.1% year over year), net income $21.4M, EPS $0.69
• Quarter ended Dec 31, 2024 (from the annual report): revenue $346M (up 5.8% year over year), net income $33.7M, EPS $1.09
• Quarter ended Sep 30, 2024: revenue $317M (up 4.0% year over year), net income $49.0M, EPS $1.57
• Quarter ended Jun 30, 2024: revenue $332M (up 4.5% year over year), net income $30.0M, EPS $0.96
• Quarter ended Mar 31, 2024: revenue $312M (up 5.7% year over year), net income $19.7M, EPS $0.63
• Quarter ended Dec 31, 2023 (from the annual report): revenue $327M (up 30.4% year over year), net income $33.1M, EPS $1.05
• Quarter ended Sep 30, 2023: revenue $305M (up 10.7% year over year), net income $15.8M, EPS $0.50
• Quarter ended Jun 30, 2023: revenue $318M (up 14.6% year over year), net income $13.7M, EPS $0.43
• Quarter ended Mar 31, 2023: revenue $295M (up 21.9% year over year), net income $1.82M, EPS $0.06
• Quarter ended Dec 31, 2022 (from the annual report): revenue $251M (down 8.4% year over year), net income $26.6M, EPS $1.02
• Quarter ended Sep 30, 2022: revenue $275M (up 10.6% year over year), net income $46.2M, EPS $1.48
• Quarter ended Jun 30, 2022: revenue $277M (up 8.6% year over year), net income −$168M, EPS −$5.65
• Quarter ended Mar 31, 2022: revenue $242M (up 4.1% year over year), net income $15.0M, EPS $0.47
• Quarter ended Dec 31, 2021 (from the annual report): revenue $274M, net income $24.4M, EPS $0.75
• Quarter ended Sep 30, 2021: revenue $249M, net income $14.9M, EPS $0.47
• Quarter ended Jun 30, 2021: revenue $255M, net income $13.3M, EPS $0.41
• Quarter ended Mar 31, 2021: revenue $233M, net income $9.86M, EPS $0.31

CNMD cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $171M, share buybacks n/a, dividends $0.60 per share
• Fiscal year ended Dec 2024: operating cash flow $167M, share buybacks n/a, dividends $0.80 per share
• Fiscal year ended Dec 2023: operating cash flow $125M, share buybacks n/a, dividends $0.80 per share
• Fiscal year ended Dec 2022: operating cash flow $33.4M, share buybacks n/a, dividends $0.80 per share
• Fiscal year ended Dec 2021: operating cash flow $112M, share buybacks n/a, dividends $0.80 per share

CNMD balance sheet

• Jun 30, 2026: cash n/a, total assets $2.30B, total liabilities $1.26B, shareholders' equity $1.04B
• Dec 31, 2025: cash n/a, total assets $2.33B, total liabilities $1.29B, shareholders' equity $1.03B
• Sep 30, 2025: cash n/a, total assets $2.32B, total liabilities $1.31B, shareholders' equity $1.01B
• Jun 30, 2025: cash n/a, total assets $2.33B, total liabilities $1.33B, shareholders' equity $1.00B
• Mar 31, 2025: cash n/a, total assets $2.30B, total liabilities $1.32B, shareholders' equity $978M
• Dec 31, 2024: cash n/a, total assets $2.31B, total liabilities $1.34B, shareholders' equity $963M
• Sep 30, 2024: cash n/a, total assets $2.32B, total liabilities $1.38B, shareholders' equity $933M
• Jun 30, 2024: cash n/a, total assets $2.29B, total liabilities $1.40B, shareholders' equity $882M

What is CNMD's revenue?

CONMED CORP reported $1.37B of revenue for the fiscal year ended December 2025.

Is CNMD profitable?

Yes. CONMED CORP earned $47.1M in its latest fiscal year.

Does CNMD pay a dividend?

CONMED CORP paid $0.60 per share in dividends in the fiscal year ended December 2025.

CNMD ownership and insider trades · All stocks